Literature DB >> 17314164

Involvement of the oncoprotein c-Myc in viral telomerase RNA gene regulation during Marek's disease virus-induced lymphomagenesis.

Marina Shkreli1, Ginette Dambrine, Denis Soubieux, Emmanuel Kut, Denis Rasschaert.   

Abstract

Marek's disease virus (MDV) is an alphaherpesvirus that induces a highly malignant T-lymphoma in chickens. The viral genome encodes two identical copies of a viral telomerase RNA subunit (vTR) that exhibits 88% sequence identity to its chicken ortholog chTR. The minimal telomerase ribonucleoprotein complex consists of a protein subunit with reverse transcriptase activity (TERT) and an RNA subunit (TR). The active complex compensates for the progressive telomere shortening that occurs during mitosis and is involved in the cell immortalization process. We show here that the upregulation of telomerase activity is associated with an increase in vTR gene expression in chickens infected with the highly oncogenic MDV strain RB-1B. A comparative functional analysis of the viral and chicken TR promoters, based on luciferase reporter assays, revealed that the vTR promoter was up to threefold more efficient than the chTR promoter in avian cells. We demonstrated, by directed mutagenesis of the vTR promoter region, that the stronger transcriptional activity of the vTR promoter resulted largely from an E-box located two nucleotides downstream from the transcriptional start site of the vTR gene. Furthermore, transactivation assays and chromatin immunoprecipitation assays demonstrated the involvement of the c-Myc oncoprotein in the transcriptional regulation of vTR. Finally, an Ets binding site was specifically implicated in the transcriptional regulation of vTR in the MDV-transformed lymphoblastoid cell line MSB-1.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17314164      PMCID: PMC1900149          DOI: 10.1128/JVI.02530-06

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  37 in total

1.  Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene.

Authors:  Jiangqin Zhao; Alan Bilsland; Stacey F Hoare; W Nicol Keith
Journal:  FEBS Lett       Date:  2003-02-11       Impact factor: 4.124

2.  Disruption of the PU.1 gene in chicken B lymphoma DT40 cells and its effect on reported target gene expression.

Authors:  Hiroki Matsudo; Akira Otsuka; Yukiko Ozawa; Masao Ono
Journal:  Gene       Date:  2003-12-11       Impact factor: 3.688

3.  X-ray structures of Myc-Max and Mad-Max recognizing DNA. Molecular bases of regulation by proto-oncogenic transcription factors.

Authors:  Satish K Nair; Stephen K Burley
Journal:  Cell       Date:  2003-01-24       Impact factor: 41.582

4.  Marek's disease virus-encoded Meq gene is involved in transformation of lymphocytes but is dispensable for replication.

Authors:  Blanca Lupiani; Lucy F Lee; Xiaoping Cui; Isabel Gimeno; Amy Anderson; Robin W Morgan; Robert F Silva; Richard L Witter; Hsing-Jien Kung; Sanjay M Reddy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-02       Impact factor: 11.205

5.  Inverted repeat nucleotide sequences in the genomes of Marek disease virus and the herpesvirus of the turkey.

Authors:  J Cebrian; C Kaschka-Dierich; N Berthelot; P Sheldrick
Journal:  Proc Natl Acad Sci U S A       Date:  1982-01       Impact factor: 11.205

6.  Estrogen receptor-alpha directs ordered, cyclical, and combinatorial recruitment of cofactors on a natural target promoter.

Authors:  Raphaël Métivier; Graziella Penot; Michael R Hübner; George Reid; Heike Brand; Martin Kos; Frank Gannon
Journal:  Cell       Date:  2003-12-12       Impact factor: 41.582

7.  Induction of telomerase activity in avian lymphoblastoid cell line transformed by Marek's disease virus, MDCC-MSB1.

Authors:  A Djeraba-AitLounis; A Djeraba-Ait Lounis; D Soubieux; W Klapper; D Rasschaert
Journal:  Vet Pathol       Date:  2004-07       Impact factor: 2.221

8.  Characterization of the chromosomal binding sites and dimerization partners of the viral oncoprotein Meq in Marek's disease virus-transformed T cells.

Authors:  Alon M Levy; Yoshihiro Izumiya; Peter Brunovskis; Liang Xia; Mark S Parcells; Sanjay M Reddy; Lucy Lee; Hong-Wu Chen; Hsing-Jien Kung
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

Review 9.  Evolving views of telomerase and cancer.

Authors:  Maria A Blasco; William C Hahn
Journal:  Trends Cell Biol       Date:  2003-06       Impact factor: 20.808

10.  Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter.

Authors:  Tim Veldman; Xuefeng Liu; Hang Yuan; Richard Schlegel
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-23       Impact factor: 12.779

View more
  12 in total

1.  Alternative splicing of a viral mirtron differentially affects the expression of other microRNAs from its cluster and of the host transcript.

Authors:  Perrine Rasschaert; Thomas Figueroa; Ginette Dambrine; Denis Rasschaert; Sylvie Laurent
Journal:  RNA Biol       Date:  2016-10-07       Impact factor: 4.652

2.  Overexpression of cellular telomerase RNA enhances virus-induced cancer formation.

Authors:  Ahmed Kheimar; Jakob Trimpert; Nicole Groenke; Benedikt B Kaufer
Journal:  Oncogene       Date:  2018-10-19       Impact factor: 9.867

3.  A p53-dependent promoter associated with polymorphic tandem repeats controls the expression of a viral transcript encoding clustered microRNAs.

Authors:  Grégoire Stik; Sylvie Laurent; Damien Coupeau; Baptiste Coutaud; Ginette Dambrine; Denis Rasschaert; Benoît Muylkens
Journal:  RNA       Date:  2010-09-29       Impact factor: 4.942

4.  Viral control of vTR expression is critical for efficient formation and dissemination of lymphoma induced by Marek's disease virus (MDV).

Authors:  Najat Chbab; Annemarie Egerer; Inês Veiga; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  Vet Res       Date:  2010-04-29       Impact factor: 3.683

5.  Alternative splicing and nonsense-mediated decay regulate telomerase reverse transcriptase (TERT) expression during virus-induced lymphomagenesis in vivo.

Authors:  Souheila Amor; Sylvie Remy; Ginette Dambrine; Yves Le Vern; Denis Rasschaert; Sylvie Laurent
Journal:  BMC Cancer       Date:  2010-10-21       Impact factor: 4.430

6.  Herpesvirus telomerase RNA(vTR)-dependent lymphoma formation does not require interaction of vTR with telomerase reverse transcriptase (TERT).

Authors:  Benedikt B Kaufer; Sascha Trapp; Keith W Jarosinski; Nikolaus Osterrieder
Journal:  PLoS Pathog       Date:  2010-08-26       Impact factor: 6.823

7.  MYC drives overexpression of telomerase RNA (hTR/TERC) in prostate cancer.

Authors:  Javier A Baena-Del Valle; Qizhi Zheng; David M Esopi; Michael Rubenstein; Gretchen K Hubbard; Maria C Moncaliano; Andrew Hruszkewycz; Ajay Vaghasia; Srinivasan Yegnasubramanian; Sarah J Wheelan; Alan K Meeker; Christopher M Heaphy; Mindy K Graham; Angelo M De Marzo
Journal:  J Pathol       Date:  2017-11-14       Impact factor: 7.996

8.  Immortalization of chicken preadipocytes by retroviral transduction of chicken TERT and TR.

Authors:  Wei Wang; Tianmu Zhang; Chunyan Wu; Shanshan Wang; Yuxiang Wang; Hui Li; Ning Wang
Journal:  PLoS One       Date:  2017-05-09       Impact factor: 3.240

Review 9.  Telomeres and Telomerase: Role in Marek's Disease Virus Pathogenesis, Integration and Tumorigenesis.

Authors:  Ahmed Kheimar; Renato L Previdelli; Darren J Wight; Benedikt B Kaufer
Journal:  Viruses       Date:  2017-07-04       Impact factor: 5.048

10.  The human telomerase catalytic subunit and viral telomerase RNA reconstitute a functional telomerase complex in a cell-free system, but not in human cells.

Authors:  Laetitia Trapp-Fragnet; Delphine T Marie-Egyptienne; Johans Fakhoury; Denis Rasschaert; Chantal Autexier
Journal:  Cell Mol Biol Lett       Date:  2012-09-01       Impact factor: 5.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.